Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jul 21, 2015 (11 years ago)

Ropivacaine HCl 0.2% in 100 mL total volume in a 100 mL Yellow…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: The firm received a complaint of a sterility failure using a non-validated sterility test on a medication cassette.

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Ropivacaine HCl 0.2% in 100 mL total volume in a 100 mL Yellow Cassette Res. Flowstop in Sodium Chloride 0.9%, Rx Only, PharMEDium Services, LLC, 6100 Global Drive, Memphis, TN 38141, NDC 61553-834-48

Affected NDC 61553-0834-48

Compare with the code on your package — it is the most precise check available.

Drug: Ropivacaine

Recalling firm
Pharmedium Services, LLC
NDC code
61553-834-48
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1428-2015 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Ropivacaine recalls

See all
Class II · Moderate risk

Fentanyl citrate

CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results.

Ongoing cGMP deviation Park Avenue Compounding NDC 83863-4272-1 D-0178-2026

Other recalls by Pharmedium Services, LLC

All 2015 recalls